Combinatorial Effect of Syringic Acid-Pyrazinamide Adduct against Luminal Type Breast Cancer Investigated through DFT, Drug-Likeness, and Molecular Docking Simulation

Mohana Priyaa Department of Bioinformatics, Bharathiar University, Coimbatore, India

Azar Zochedhb Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil, IndiaCorrespondence[email protected]

https://orcid.org/0000-0001-9818-5071

Karthikeyan Palaniyandic Department of Physics, Condensed Matter Physics Laboratory, International Research Center, Kalasalingam Academy of Research and Education, Krishnankoil, India

https://orcid.org/0009-0007-1003-1571

Athimoolam Shunmuganarayanand Department of Physics, University College of Engineering, Anna University, Nagercoil, India

https://orcid.org/0000-0001-7250-7204

Asath Bahadur Sultanc Department of Physics, Condensed Matter Physics Laboratory, International Research Center, Kalasalingam Academy of Research and Education, Krishnankoil, IndiaCorrespondence[email protected] [email protected]

https://orcid.org/0000-0002-4552-7354

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kaliraj Chandran, Azar Zochedh, Asath Bahadur Sultan & Thandavarayan Kathiresan. (2023) Synthesis of 1-Piperoylpiperidine Investigated Through Spectroscopy, Quantum Computation, Pharmaceutical Activity, Docking and MD Simulation Against Breast Cancer. Polycyclic Aromatic Compounds 0:0, pages 1-35.
Read now

Azar Zochedh, Kaliraj Chandran, Athimoolam Shunmuganarayanan & Asath Bahadur Sultan. (2023) Exploring the Synergistic Effect of Tegafur-Syringic Acid Adduct Against Breast Cancer through DFT Computation, Spectroscopy, Pharmacokinetics and Molecular Docking Simulation. Polycyclic Aromatic Compounds 0:0, pages 1-35.
Read now

Articles from other publishers (1)

Sureba Sukumaran, Azar Zochedh, Kaliraj Chandran, Asath Bahadur Sultan & Thandavarayan Kathiresan. (2024) Exploring the co‐activity of FDA approved drug gemcitabine and docetaxel for enhanced anti‐breast cancer activity: DFT , docking, molecular dynamics simulation and pharmacophore studies . International Journal of Quantum Chemistry 124:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Combinatorial Effect of Syringic Acid-Pyrazinamide Adduct against Luminal Type Breast Cancer Investigated through DFT, Drug-Likeness, and Molecular Docking Simulation

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combinatorial Effect of Syringic Acid-Pyrazinamide Adduct against Luminal Type Breast Cancer Investigated through DFT, Drug-Likeness, and Molecular Docking Simulation

Citations (3)

Read on this site (2)

Articles from other publishers (1)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date